EPTIS
BAM Logo

HLA-12 Histocompatibility scheme - Detection and specificity test of anti HPAantibodies

[HLA-12 Detección y análisis de anticuerpos anti HPA]

EPTIS factsheet 663978 | Last revision 2020-02-26 | URL: https://www.eptis.bam.de/pts663978 https://www.eptis.bam.de/pts663978

PT provider
PT provider GECLID-SEI (External Quality for Diagnostic Immunology Laboratories under the auspices of the Spanish Society for Immunology) GECLID-SEI (External Quality for Diagnostic Immunology Laboratories under the auspices of the Spanish Society for Immunology)
Based in Spain
Language(s) English and Spanish
Remarks
Keywords
Product groups Health care / medical devices
Human test material
Testing fields Biology
Medical analysis
Technical details
Test item Tested property Testing method
Serum (stabilized) Anti HPA antibodies detection LSA
-
Anti HPA antibodies ID LSA
-
Aims of the PT scheme
Target group of participants
Linked to specific legislation / standards
Additional, subsidiary aims
Number of participants 5
Accredited or otherwise reviewed by a 3rd party

ISO 9001:2015 certified

Operation is commissioned / requested by
Fees and frequency
Participation fee 123,5 EU
Regularly operated Yes (Once a year)
Year of first operation 2019
Contact details of the PT provider
Provider Contact person
GECLID-SEI (External Quality for Diagnostic Immunology Laboratories under the auspices of the Spanish Society for Immunology)
Pº de Filipinos s/n
47007 Valladolid
Spain

Phone: +34 983 41 88 23 Ext.89673
Fax:
Web: https://www.geclid.es https://www.geclid.es
Dr. Carmen Martin
Phone: +34 686 247 331
Fax:
Email: responsable@geclid.es responsable@geclid.es
If you find any mistakes please contact the responsible EPTIS coordinator in Spain, Mr Miquel Navarro. Mr Miquel Navarro.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.21